Botanix Pharmaceuticals Limited Price Chart
Botanix Pharmaceuticals Limited BOT.XA Financial and Trading Overview
| Botanix Pharmaceuticals Limited stock price | 0.27 AUD |
| Previous Close | 0.11 AUD |
| Open | 0.11 AUD |
| Bid | 0.1 AUD x N/A |
| Ask | 0.12 AUD x N/A |
| Day's Range | 0.11 - 0.12 AUD |
| 52 Week Range | 0.05 - 0.12 AUD |
| Volume | 1.11M AUD |
| Avg. Volume | 903.7K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.948659 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.011 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BOT.XA Valuation Measures
| Enterprise Value | 116M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 7.4999995 |
| Enterprise Value/Revenue | 17.028 |
| Enterprise Value/EBITDA | -10.31 |
Trading Information
Botanix Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 1.948659 |
| 52-Week Change | 77.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.12 AUD |
| 52 Week Low | 0.05 AUD |
| 50-Day Moving Average | 0.09 AUD |
| 200-Day Moving Average | 0.07 AUD |
BOT.XA Share Statistics
| Avg. Volume (3 month) | 903.7K AUD |
| Avg. Daily Volume (10-Days) | 779.5K AUD |
| Shares Outstanding | N/A |
| Float | 966.32M |
| Short Ratio | N/A |
| % Held by Insiders | 20.83% |
| % Held by Institutions | 9.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -165.27% |
| Operating Margin (ttm) | -165.45% |
| Gross Margin | -69.51% |
| EBITDA Margin | -165.16% |
Management Effectiveness
| Return on Assets (ttm) | -36.99% |
| Return on Equity (ttm) | -72.23% |
Income Statement
| Revenue (ttm) | 6.81M AUD |
| Revenue Per Share (ttm) | 0.007 AUD |
| Quarterly Revenue Growth (yoy) | 8428.10% |
| Gross Profit (ttm) | -7537672 AUD |
| EBITDA | -11251809 AUD |
| Net Income Avi to Common (ttm) | -11258940 AUD |
| Diluted EPS (ttm) | -0.011 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.72M AUD |
| Total Cash Per Share (mrq) | 0.007 AUD |
| Total Debt (mrq) | 32.42K AUD |
| Total Debt/Equity (mrq) | 0.19 AUD |
| Current Ratio (mrq) | 3.082 |
| Book Value Per Share (mrq) | 0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12285044 AUD |
| Levered Free Cash Flow (ttm) | -16271205 AUD |
Profile of Botanix Pharmaceuticals Limited
| Country | Australia |
| State | WA |
| City | Leederville |
| Address | D2, 661 Newcastle Street |
| ZIP | 6007 |
| Phone | 61 8 6555 2945 |
| Website | https://www.botanixpharma.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 11 |
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.
Q&A For Botanix Pharmaceuticals Limited Stock
What is a current BOT.XA stock price?
Botanix Pharmaceuticals Limited BOT.XA stock price today per share is 0.27 AUD.
How to purchase Botanix Pharmaceuticals Limited stock?
You can buy BOT.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Botanix Pharmaceuticals Limited?
The stock symbol or ticker of Botanix Pharmaceuticals Limited is BOT.XA.
How many shares does Botanix Pharmaceuticals Limited have in circulation?
The max supply of Botanix Pharmaceuticals Limited shares is 0.
What is Botanix Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
Botanix Pharmaceuticals Limited PE Ratio is now.
What was Botanix Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
Botanix Pharmaceuticals Limited EPS is -0.011 AUD over the trailing 12 months.